{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:34:07Z","timestamp":1792442047025,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pediatr Card"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/0974-2069.79616","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T03:51:10Z","timestamp":1302839470000},"page":"4","source":"Crossref","is-referenced-by-count":61,"title":["Global research priorities in rheumatic fever and rheumatic heart disease"],"prefix":"10.4103","volume":"4","author":[{"given":"JonathanR","family":"Carapetis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LieslJ","family":"Z\u00fchlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-2069.79616-1","unstructured":"WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease (2001: Geneva Switzerland). Rheumatic fever and rheumatic heart disease: Report of a WHO Expert Consultation, Geneva, 29 October - 1 November 2001. WHO Technical Report Series; 923. Geneva: World Health Organization; 2004."},{"key":"key-10.4103\/0974-2069.79616-2","first-page":"1066","volume-title":"Evaluation of the WHO clinical decision rule for streptococcal pharyngitis","author":"Rimoin","year":"2005","journal-title":"Arch Dis Child"},{"key":"key-10.4103\/0974-2069.79616-3","unstructured":"Carapetis JR, Steer AC, Mulholland EK. The current evidence for the burden of group A streptococcal diseases (WHO\/FCH\/CAH\/05.07). Geneva: World Health Organization; 2004."},{"key":"key-10.4103\/0974-2069.79616-4","unstructured":"Carapetis JR. Group A streptococcal vaccine development: Current status and issues of relevance to less developed countries (WHO\/FCH\/CAH\/05.09 and WHO\/IVB\/05.14). Geneva: World Health Organization; 2004."},{"key":"key-10.4103\/0974-2069.79616-5","unstructured":"Carapetis JR. A review of the technical basis for the current WHO approach to the control of conditions associated with group A streptococcal infections (WHO\/FCH\/CAH\/05.08). Geneva: World Health Organization; 2004."},{"key":"key-10.4103\/0974-2069.79616-6","first-page":"246","volume-title":"The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa","author":"Mayosi","year":"2006","journal-title":"S Afr Med J"},{"key":"key-10.4103\/0974-2069.79616-7","first-page":"1517","volume-title":"Rheumatic heart disease and its control in the Pacific","author":"Colquhoun","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"key-10.4103\/0974-2069.79616-8","unstructured":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia: An evidence-based review. Melbourne: National Heart Foundation of Australia; 2006."},{"key":"key-10.4103\/0974-2069.79616-9","first-page":"282","volume-title":"Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India","author":"Kumar","year":"1997","journal-title":"Indian Heart J"},{"key":"key-10.4103\/0974-2069.79616-10","first-page":"644","volume-title":"10-year educational programme aimed at rheumatic fever in two French Caribbean islands","author":"Bach","year":"1996","journal-title":"Lancet"},{"key":"key-10.4103\/0974-2069.79616-11","first-page":"282","volume-title":"Rheumatic heart disease in indigenous populations--New Zealand experience","author":"Wilson","year":"2010","journal-title":"Heart Lung Circ"},{"key":"key-10.4103\/0974-2069.79616-12","first-page":"1534","volume-title":"Incidence of acute rheumatic fever in the world: A systematic review of population-based studies","author":"Tibazarwa","year":"2008","journal-title":"Heart"},{"key":"key-10.4103\/0974-2069.79616-13","first-page":"685","volume-title":"The global burden of group A streptococcal diseases","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0974-2069.79616-14","first-page":"417","volume-title":"The quality of management of rheumatic fever\/heart disease in the Kimberly","author":"Mincham","year":"2002","journal-title":"Aust N Z J Public Health"},{"key":"key-10.4103\/0974-2069.79616-15","first-page":"514","volume-title":"Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community (mm ref 2769)","author":"Harrington","year":"2006","journal-title":"Med J Aust"},{"key":"key-10.4103\/0974-2069.79616-16","first-page":"21","volume-title":"Understanding uptake of continuous quality improvement in Indigenous primary health care: Lessons from a multi-site case study of the Audit and Best Practice for Chronic Disease project","author":"Gardner","year":"2010","journal-title":"Implement Sci"},{"key":"key-10.4103\/0974-2069.79616-17","first-page":"17","volume-title":"Differences in serum penicillin concentrations following intramuscular injection of benzathine penicillin G (BPG) from different manufacturers","author":"Zaher","year":"1992","journal-title":"J Pharm Med"},{"key":"key-10.4103\/0974-2069.79616-18","first-page":"1571","volume-title":"Prophylaxis against group A streptococcal infections in rheumatic fever patients; Use of new repository penicillin preparation","author":"Stollerman","year":"1952","journal-title":"J Am Med Assoc"},{"key":"key-10.4103\/0974-2069.79616-19","first-page":"992","volume-title":"Rheumatic fever prophylaxis using benzathine penicillin G (BPG): Two- Week versus four-week regimens: Comparison of two brands of BPG","author":"Kassem","year":"1996","journal-title":"Pediatrics"},{"key":"key-10.4103\/0974-2069.79616-20","first-page":"146","volume-title":"Pharmacokinetics of benzathine penicillin G: Serum levels during the 28 days after intramuscular injection of 1,200,000 units","author":"Kaplan","year":"1989","journal-title":"J Pediatr"},{"key":"key-10.4103\/0974-2069.79616-21","doi-asserted-by":"crossref","unstructured":"Bass JW, Longfield JN, Jones RG, Hartmann RM. Serum levels of penicillin in basic trainees in the U.S. Army who received intramuscular penicillin G benzathine. Clin Infect Dis 1996;22:727-8.","DOI":"10.1093\/clinids\/22.4.727"},{"key":"key-10.4103\/0974-2069.79616-22","first-page":"23","volume-title":"Blood naltrexone levels over time following naltrexone implant","author":"Ngo","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key-10.4103\/0974-2069.79616-23","first-page":"135","volume-title":"Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996-2002)","author":"Nordet","year":"2008","journal-title":"Cardiovasc J Afr"},{"key":"key-10.4103\/0974-2069.79616-24","unstructured":"Michaud C, Rammohan R, Narula J. Cost-effectiveness analysis of intervention strategies for reduction of the burden of rheumatic heart disease. In: Narula J, Virmani R, Reddy KS, Tandon R, editors. Rheumatic fever. Washington DC: American Registry of Pathology; 1999. p. 485-97."},{"key":"key-10.4103\/0974-2069.79616-25","unstructured":"Michaud C, Gutierrez J, Cruz C, Pearson T. The World Bank health sector priorities review: Rheumatic heart disease. World Bank ,Washington, D C; 1991. p. 1-31."},{"key":"key-10.4103\/0974-2069.79616-26","first-page":"138","volume-title":"Outcomes of cardiac valve replacement for rheumatic heart disease in Aboriginal Australians","author":"Carapetis","year":"2000","journal-title":"Asia Pac Heart J"},{"key":"key-10.4103\/0974-2069.79616-27","first-page":"36S","volume-title":"Antithrombotic therapy in valvular heart disease","author":"Levine","year":"1986","journal-title":"Chest"},{"key":"key-10.4103\/0974-2069.79616-28","first-page":"457S","volume-title":"Antithrombotic therapy in valvular heart disease--native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","author":"Salem","year":"2004","journal-title":"Chest"},{"key":"key-10.4103\/0974-2069.79616-29","first-page":"7","volume-title":"The initial attack of acute rheumatic fever during childhood in North India; A prospective study of the clinical profile","author":"Sanyal","year":"1974","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.79616-30","doi-asserted-by":"crossref","unstructured":"Feinstein AR, Wood HF, Spagnuolo M, Taranta A, Jonas S, Kleinberg E, et al. Rheumatic Fever in Children and Adolescents. A Long-Term Epidemiologic Study of Subsequent Prophylaxis, Streptococcal Infections, and Clinical Sequelae. Vii. Cardiac Changes and Sequelae. Ann Intern Med 1964;60:87-123.","DOI":"10.7326\/0003-4819-60-2-87"},{"key":"key-10.4103\/0974-2069.79616-31","first-page":"1809","volume-title":"Prevalence of rheumatic heart disease in children and young adults in Nicaragua","author":"Paar","year":"2010","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0974-2069.79616-32","first-page":"470","volume-title":"Prevalence of rheumatic heart disease detected by echocardiographic screening","author":"Marijon","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-2069.79616-33","first-page":"411","volume-title":"Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren","author":"Carapetis","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key-10.4103\/0974-2069.79616-34","first-page":"353","volume-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"key":"key-10.4103\/0974-2069.79616-35","first-page":"481","volume-title":"Diagnosis of rheumatic fever","author":"Jones","year":"1944","journal-title":"JAMA"},{"key":"key-10.4103\/0974-2069.79616-36","unstructured":"Heart Foundation of New Zealand and Cardiac Society of Australia and New Zealand. New Zealand Guidelines for Rheumatic Fever. 1. Diagnosis, management and secondary prevention. Auckland: Heart Foundation of New Zealand; 2006."},{"key":"key-10.4103\/0974-2069.79616-37","first-page":"205","volume-title":"Acute rheumatic fever: An important differential diagnosis of septic arthritis","author":"Mataika","year":"2008","journal-title":"J Trop Pediatr"},{"key":"key-10.4103\/0974-2069.79616-38","first-page":"CD003176","volume-title":"Anti-inflammatory treatment for carditis in acute rheumatic fever","author":"Cilliers","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-2069.79616-39","first-page":"83","volume-title":"Autoantigens identified by screening a human heart cDNA library with acute rheumatic fever sera","author":"Towers","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0974-2069.79616-40","first-page":"1094","volume-title":"Genetic contribution to rheumatic fever: A systematic review and meta-analysis of twin studies.[Presented at the 8th National Congress of the South African Heart Association, Sun City, 22-25 November 2007]","author":"Engel","year":"2007","journal-title":"S Afr Med J"},{"key":"key-10.4103\/0974-2069.79616-41","first-page":"742","volume-title":"Some of the people, some of the time: Susceptibility to acute rheumatic fever","author":"Bryant","year":"2009","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.79616-42","first-page":"709","volume-title":"Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?","author":"Karthikeyan","year":"2009","journal-title":"Circulation"},{"key":"key-10.4103\/0974-2069.79616-43","first-page":"91","volume-title":"Prevention of rheumatic fever","author":"Carapetis","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0974-2069.79616-44","first-page":"e384; author reply e5","volume-title":"Letter by Carapetis regarding article, \"Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?","author":"Carapetis","year":"2010","journal-title":"\" Circulation"},{"key":"key-10.4103\/0974-2069.79616-45","first-page":"787","volume-title":"School-based prevention of acute rheumatic fever: A group randomized trial in New Zealand","author":"Lennon","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0974-2069.79616-46","first-page":"e259","volume-title":"Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever","author":"Lennon","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0974-2069.79616-47","first-page":"240","volume-title":"Acute rheumatic fever: A chink in the chain that links the heart to the throat?","author":"McDonald","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0974-2069.79616-48","first-page":"34","volume-title":"Control of scabies, skin sores and haematuria in children in the Solomon Islands: Another role for ivermectin","author":"Lawrence","year":"2005","journal-title":"Bull World Health Organ"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:53:10Z","timestamp":1786632790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-2069.79616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"alternative-id":["79616"],"URL":"https:\/\/doi.org\/10.4103\/0974-2069.79616","relation":{},"ISSN":["0974-2069"],"issn-type":[{"value":"0974-2069","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}